Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25
Brand: ProteoGenix

Pembrolizumab Biosimilar – Anti-PD1 mAb – Research Grade

Isotype:
IgG4

€120.00

100ug + 120 loyalty points
Size
Clear
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery
SDS-PAGE for Pembrolizumab Biosimilar - Anti-PD1 mAb
Pembrolizumab Biosimilar - Anti-PD1 mAb binds to CD279 Recombinant Protein in indirect ELISA Assay

Pembrolizumab Biosimilar - Anti-PD1 mAb - Research Grade

Product name Pembrolizumab Biosimilar - Anti-PD1 mAb - Research Grade
Source DrugBank DB09037
Species Human
Expression system Mammalian cells
Molecular weight 149kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Aliases /Synonyms Pembrolizumab,Pembrolizumab,PD1,anti-PD1
Reference PX-TA1007
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4
Product name Pembrolizumab Biosimilar - Anti-PD1 mAb - Research Grade
Source DrugBank DB09037
Species Human
Expression system Mammalian cells
Molecular weight 149kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Aliases /Synonyms Pembrolizumab,Pembrolizumab,PD1,anti-PD1
Reference PX-TA1007
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4
Product name Pembrolizumab Biosimilar - Anti-PD1 mAb - Research Grade
Source DrugBank DB09037
Species Human
Expression system Mammalian cells
Molecular weight 149kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Pembrolizumab,Pembrolizumab,PD1,anti-PD1
Reference PX-TA1007
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4
Clonality Monoclonal Antibody
Product name Pembrolizumab Biosimilar - Anti-PD1 mAb - Research Grade
Source DrugBank DB09037
Species Human
Expression system Mammalian cells
Molecular weight 149kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Pembrolizumab,Pembrolizumab,PD1,anti-PD1
Reference PX-TA1007
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4
Clonality Monoclonal Antibody

General information about Pembrolizumab

Pembrolizumab is a humanized antibody used in cancer immunotherapy. This includes to treat melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer. It is given by slow injection into a vein. It is an IgG4 isotype antibody that blocks a protective mechanism of cancer cells and thereby, allows the immune system to destroy them. It targets the programmed cell death protein 1 (PD-1) receptor of lymphocytes. It works by targeting the cellular pathway of proteins found on the body’s immune cells and some cancer cells, known as PD-1/PD-L1. This product is for research use only.

SDS-PAGE for Pembrolizumab Biosimilar - Anti-PD1 mAb

SDS-PAGE for Pembrolizumab Biosimilar - Anti-PD1 mAb

Pembrolizumab Biosimilar - Anti-PD1 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Pembrolizumab Biosimilar - Anti-PD1 mAb binds to CD279 Recombinant Protein in indirect ELISA Assay

Pembrolizumab Biosimilar - Anti-PD1 mAb binds to CD279 Recombinant Protein in indirect ELISA Assay

Immobilized CD279 Recombinant Protein (cat. No.PX-P4117) at 0.5µg/mL (100µL/well) can bind to Pembrolizumab Biosimilar - Anti-PD1 mAb (cat. No.PX-TA1007) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

There are no reviews yet.

Be the first to review “Pembrolizumab Biosimilar – Anti-PD1 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products